We are live on ! Find out more
PBYI icon

Puma Biotechnology
PBYI

136 hedge funds and large institutions have $1.41B invested in Puma Biotechnology in 2017 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 45 increasing their positions, 32 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

84% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 19

41% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 32

32% more capital invested

Capital invested by funds: $1.07B → $1.41B (+$340M)

7.87% more ownership

Funds ownership: 94.87% → 102.74% (+7.9%)

6% more funds holding

Funds holding: 128 → 136 (+8)

9% less call options, than puts

Call options by funds: $16.8M | Put options by funds: $18.5M

Holders
136
Holders Change
+8
Holders Change %
+6.25%
% of All Funds
3.39%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
35
Increased
45
Reduced
32
Closed
19
Calls
$16.8M
Puts
$18.5M
Net Calls
-$1.71M
Net Calls Change
-$13M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$63.4M
2
PC
PointState Capital
New York
+$28.1M
3
CCM
Camber Capital Management
Massachusetts
+$23.7M
4
FCM
Farallon Capital Management
California
+$21.2M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.2M

Top Sellers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
-$33.7M
2
State Street
State Street
Massachusetts
-$16.3M
3
Morgan Stanley
Morgan Stanley
New York
-$16.2M
4
Citigroup
Citigroup
New York
-$5.22M
5
JP
Jana Partners
New York
-$4.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
26
Tekla Capital Management
Massachusetts
$9.68M – – –
BB
27
BB Biotech
Switzerland
$9.14M +$132K +3,625 +1%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$8.64M +$1.25M +34,190 +17%
GTC
29
Ghost Tree Capital
New York
$8.37M +$8.21M +225,000 New
Deutsche Bank
30
Deutsche Bank
Germany
$7.7M -$3.28M -89,924 -30%
Renaissance Technologies
31
Renaissance Technologies
New York
$7.68M +$7.53M +206,500 New
SCM
32
Sio Capital Management
New York
$5.95M +$5.84M +160,064 New
Bank of America
33
Bank of America
North Carolina
$5.88M -$3.38M -92,500 -37%
HI
34
HBK Investments
Texas
$5.83M +$2.93M +80,197 +105%
CS
35
Candriam SCA
Luxembourg
$5.75M +$1.64M +45,000 +41%
Federated Hermes
36
Federated Hermes
Pennsylvania
$5.67M +$5.1M +139,838 +1,104%
TA
37
Teachers Advisors
New York
$5.4M +$103K +2,824 +2%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$4.99M -$860K -23,561 -15%
Charles Schwab
39
Charles Schwab
California
$4.44M +$224K +6,138 +5%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$3.96M +$3.55M +97,176 +1,064%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$3.9M -$168K -4,600 -4%
BC
42
Boxer Capital
California
$3.72M +$3.65M +100,000 New
TCIM
43
TIAA CREF Investment Management
New York
$3.57M -$515K -14,113 -13%
RSCM
44
Rock Springs Capital Management
Maryland
$3.52M – – –
MWNA
45
Marshall Wace North America
New York
$3.48M +$3.43M +94,090 New
Capital Fund Management (CFM)
46
Capital Fund Management (CFM)
France
$3.26M +$3.2M +87,755 New
BCPEM
47
Bain Capital Public Equity Management
Massachusetts
$3.23M +$3.16M +86,700 New
JP Morgan Chase
48
JP Morgan Chase
New York
$3.17M -$154K -4,231 -5%
CS
49
Credit Suisse
Switzerland
$3.08M +$1.49M +40,890 +98%
Morgan Stanley
50
Morgan Stanley
New York
$2.86M -$16.2M -445,244 -85%
1
2
3 4 5

PBYI Hedge Fund Activity: Q1 2017 in Review

136 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Puma Biotechnology (PBYI) for Q1 2017, worth a combined $1.41B — up 32% from $1.07B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new PBYI positions and 19 closed out — a net gain of 16 holders — while 45 added to existing stakes and 32 trimmed.

The largest buyer was BlackRock, adding an estimated $63.4M. The largest seller was American Century Companies, cutting an estimated $33.7M.

  • 136 institutional investors held Puma Biotechnology (PBYI) as of Q1 2017, up from 128 in Q4 2016.
  • Funds reported $1.41B of Puma Biotechnology stock for Q1 2017, up 32% quarter-over-quarter.
  • 35 funds opened new Puma Biotechnology positions in Q1 2017 and 19 closed out, a net change of +16 holders.
  • The largest Puma Biotechnology buyer in Q1 2017 was BlackRock, an estimated $63.4M added.
  • The largest Puma Biotechnology seller in Q1 2017 was American Century Companies, an estimated $33.7M sold.

Based on aggregated 13F filings for Q1 2017.